Stockscreener 앱 받기
5.11
0.00%
0.00
시장 영업 전:
5.06
-0.05
-0.98%
전일 마감가:
$5.11
열려 있는:
$5.1
하루 거래량:
282.16K
Relative Volume:
0.63
시가총액:
$304.30M
수익:
-
순이익/손실:
$-44.80M
주가수익비율:
-6.8133
EPS:
-0.75
순현금흐름:
$-30.67M
1주 성능:
-2.11%
1개월 성능:
-2.29%
6개월 성능:
+50.29%
1년 성능:
+51.63%
1일 변동 폭
$4.95
$5.2184
1주일 범위
$4.95
$5.58
52주 변동 폭
$2.71
$6.5476
Aldeyra Therapeutics Inc Stock (ALDX) Company Profile
명칭
Aldeyra Therapeutics Inc
전화
781-761-4904
주소
131 HARTWELL AVENUE, LEXINGTON, MA
ALDX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALDX
Aldeyra Therapeutics Inc
|
5.11 | 304.30M | 0 | -44.80M | -30.67M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.11 | 106.13B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.59 | 80.61B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
649.26 | 38.82B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
240.55 | 31.03B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
122.15 | 29.28B | 3.30B | -501.07M | 1.03B | -2.1146 |
Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-03 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2024-04-02 | 재개 | H.C. Wainwright | Buy |
| 2022-04-27 | 재개 | H.C. Wainwright | Buy |
| 2021-02-08 | 개시 | H.C. Wainwright | Buy |
| 2020-12-16 | 개시 | Berenberg | Buy |
| 2020-10-30 | 개시 | Jefferies | Buy |
| 2020-10-16 | 개시 | BTIG Research | Buy |
| 2020-09-22 | 개시 | Alliance Global Partners | Buy |
| 2020-05-12 | 개시 | Oppenheimer | Outperform |
| 2018-12-04 | 개시 | Citigroup | Buy |
| 2018-09-26 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-09-13 | 개시 | Janney | Buy |
| 2018-01-26 | 개시 | Seaport Global Securities | Buy |
| 2016-09-26 | 개시 | H.C. Wainwright | Buy |
| 2016-07-01 | 개시 | Stifel | Buy |
| 2015-07-01 | 개시 | Canaccord Genuity | Buy |
| 2015-03-25 | 개시 | Chardan Capital Markets | Buy |
| 2015-03-20 | 재확인 | H.C. Wainwright | Buy |
| 2014-11-18 | 개시 | H.C. Wainwright | Buy |
| 2014-06-19 | 개시 | Aegis Capital | Buy |
모두보기
Aldeyra Therapeutics Inc 주식(ALDX)의 최신 뉴스
Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Shares Bought by Barclays PLC - Defense World
Geode Capital Management LLC Has $6.01 Million Holdings in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World
3 US Penny Stocks With Market Caps Over $80M To Watch - Simply Wall St
State Street Corp Purchases 16,188 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World
Aldeyra Therapeutics (NASDAQ:ALDX) Stock Crosses Below 50 Day Moving AverageTime to Sell? - MarketBeat
Aldeyra, UnitedHealth Group Incorporated, Blue Ridge Bankshares, and Amplitude Investigation - The Bakersfield Californian
Aldeyra, UnitedHealth Group Incorporated, Blue Ridge - GlobeNewswire
Aldeyra Therapeutics: Key Inflection Point Ahead (NASDAQ:ALDX) - Seeking Alpha
4 Stock-ing Stuffers for Under $10 a Share - TheStreet
High Growth Tech Stocks To Watch In December 2024 - Simply Wall St
BNP Paribas Financial Markets Acquires 10,201 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World
Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Shares Sold by Verition Fund Management LLC - MarketBeat
Is the Options Market Predicting a Spike in Aldeyra Therapeutics (ALDX) Stock? - MSN
Aldeyra stock retains Outperform rating on strong DED drug outlook By Investing.com - Investing.com Australia
Aldeyra stock retains Outperform rating on strong DED drug outlook - Investing.com
Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Short Interest Down 12.3% in November - Defense World
Short Interest in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Drops By 12.3% - MarketBeat
Objective long/short (ALDX) Report - Stock Traders Daily
Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Shares Purchased by Jacobs Levy Equity Management Inc. - MarketBeat
Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Sees Large Increase in Short Interest - MarketBeat
Aldeyra Therapeutics CEO to Present at Citi Healthcare Conference Ophthalmology Panel - StockTitan
Final Deadline Alert: ALDX Investor Alert: Contact Bronstein, Ge - GuruFocus.com
Eagle Asset Management Inc. Lowers Stock Position in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - MarketBeat
ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap - MSN
Aldeyra announces FDA acceptance of resubmitted reproxalap application - MSN
Top US Penny Stocks To Watch In November 2024 - Simply Wall St
Perceptive Advisors buys 200,000 shares of Aldeyra Therapeutics Inc's common stock on Sept 19 - Reuters.com
Aldeyra Therapeutics (ALDX) Refiles NDA for Innovative Dry Eye Drug Reproxalap - GuruFocus.com
5,578 Shares in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Bought by US Bancorp DE - Defense World
BTIG sets shares target with buy rating on Aldeyra, cites FDA read - Investing.com
Aldeyra Therapeutics Shares Up, FDA to Review New Drug Application - MarketWatch
FDA reviews Aldeyra's dry eye disease drug candidate By Investing.com - Investing.com Canada
Aldeyra announces FDA acceptance of resubmitted reproxalap application (NASDAQ:ALDX) - Seeking Alpha
FDA reviews Aldeyra's dry eye disease drug candidate - Investing.com
Aldeyra's Dry Eye Drug Gets FDA Review, Expands $400M AbbVie Partnership Deal | ALDX Stock News - StockTitan
What is Leerink Partnrs' Forecast for ALDX FY2024 Earnings? - MarketBeat
Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Short Interest Update - MarketBeat
Research Analysts Issue Forecasts for ALDX FY2028 Earnings - MarketBeat
Aldeyra Therapeutics CEO to Present at Jefferies London Healthcare Conference | ALDX Stock News - StockTitan
Aldeyra Therapeutics Insiders Who Sold Avert US$58m Market Cap Dip - Simply Wall St
Aldeyra’s FDA Resubmission And AbbVie Option Revitalize Reproxalap’s Prospects (ALDX) - Seeking Alpha
Nephrotic Syndrome Drugs Market Analysis of the Competitive - openPR
Is BellRing Brands (BRBR) Outperforming Other Medical Stocks This Year? - Yahoo Finance
(ALDX) Trading Advice - Stock Traders Daily
Aldeyra Therapeutics Inc (ALDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.08%
0.05%
자본화:
|
볼륨(24시간):